Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | iC9.CAR-CSPG4 T-cells |
| Trade Name | |
| Synonyms | Autologous anti-CSPG4 CAR-iC9-expressing T-lymphocytes |
| Drug Descriptions |
iC9.CAR-CSPG4 T-cells are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CSPG4 and also express inducible caspase-9, which potentially induce killing of tumor cells expressing CSPG4 (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C202939 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| iC9.CAR-CSPG4 T-cells | iC9.CAR-CSPG4 T-cells | 0 | 1 |